Authors:
Morita, S
Gebska, MA
Kakkar, AK
Scully, MF
Citation: S. Morita et al., High affinity binding of heparin by necrotic tumour cells neutralises anticoagulant activity - Implications for cancer related thromboembolism and heparin therapy, THROMB HAEM, 86(2), 2001, pp. 616-622
Authors:
Skordalakes, E
Dodson, GG
Green, DS
Goodwin, CA
Scully, MF
Hudson, HR
Kakkar, VV
Deadman, JJ
Citation: E. Skordalakes et al., Inhibition of human alpha-thrombin by a phosphonate tripeptide proceeds via a metastable pentacoordinated phosphorus intermediate, J MOL BIOL, 311(3), 2001, pp. 549-555
Authors:
Green, D
Elgendy, S
Patel, G
Skordalakes, E
Goodwin, CA
Scully, MF
Kakkar, VV
Deadman, JJ
Citation: D. Green et al., Substrate related O,O-dialkyldipeptidyl Psi carboxybenzylphosphonates, a new type of thrombin inhibitor, PHOSPHOR SU, 156, 2000, pp. 151-155
Authors:
Monagle, P
Adams, M
Mahoney, M
Ali, K
Barnard, D
Bernstein, M
Brisson, L
David, M
Desai, S
Scully, MF
Halton, J
Israels, S
Jardine, L
Leaker, M
McCusker, P
Silva, M
Wu, J
Anderson, R
Andrew, M
Massicotte, MP
Citation: P. Monagle et al., Outcome of pediatric thromboembolic disease: A report from the Canadian Childhood Thrombophilia Registry, PEDIAT RES, 47(6), 2000, pp. 763-766
Authors:
Green, D
Skordalakes, E
Scully, MF
Goodwin, C
Merette, S
Burd, A
Kakkar, VV
Deadman, J
Citation: D. Green et al., X-ray crystallographic analyses of human alpha-thrombin complexed to peptidy aminophosphonates: Evidence of a binding mechanism, PHOSPHOR SU, 146, 1999, pp. 545-548